Bio-Works Technologies
Bio-Works Receives Order Worth SEK 2.4 Million from New European Customer in Vaccine Production
REG
"We see it as a strong endorsement that a new player in vaccine production chooses Bio-Works as a supplier. This strengthens our position in the European market," says Lone Carlbom, CEO of Bio-Works Technologies AB.
The delivery concerns products used in the production process and represents a potential for long-term collaboration.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 29-04-2025 16:04 CET.
| Datum | 2025-04-29, kl 16:04 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!